Neck News and Research

RSS

Common drug used to treat Burkitt lymphoma can activate EBV: Study

Important advances in the fight against cancer have come as researchers proved that viruses and cancers interact in ways that were previously unknown to scientists.

13 Apr 2010

Health care experts brand plan for a “Big Australia” as disaster waiting to happen

Increased immigration rates are set to make Australia’s population hit 36 million by the year 2050 according to Federal Government estimates. This would be a huge leap from the present 22,300,000 people that the nation has today. The added population is being seen as a necessity to ensure economical survival for the country.

13 Apr 2010

As overall cancer rates decline in the U.S., thyroid cancer counters the trend

As overall cancer rates are declining in the United States, thyroid cancer counters the trend. It's being diagnosed more frequently, especially in women. Women are three times more likely than men to develop thyroid cancer.

9 Apr 2010

First proton therapy center for New Jersey

Cancer survivors joined representatives from ProCure Treatment Centers, Inc., Princeton Radiation Oncology, and CentraState Healthcare System to break ground on the ProCure Proton Therapy Center in Somerset - the first proton therapy center to be built in the state, located 40 miles from downtown Manhattan.

8 Apr 2010

Loyola University Medical Center to offer free screenings for oral, head and neck cancer

Oral, head and neck cancers — most of which are preventable — account for approximately 3 percent of all cancer cases in the United States, according to the American Cancer Society. In 2009, more than 35,000 Americans were diagnosed with these cancers and 7,600 died.

8 Apr 2010

Increase in proportion of older middle-aged Americans who report mobility-related difficulties: Study

The proportion of older middle-aged Americans who report disabilities related to mobility increased significantly from 1997 to 2007, in contrast to the disability decline that has been found among Americans ages 65 and over, according to a new study by the RAND Corporation and the University of Michigan.

6 Apr 2010

Johns Hopkins Kimmel Cancer Center reviews top cancer stories

Surgeon Jeremy Richmon, M.D., at Johns Hopkins is using robotic assistance to cut away tumors of the tongue and tonsils. Conventional surgery leaves disfiguring neck and jaw scars, but the robotic procedure leaves no scar except for inside the mouth, and he says, patients retain good function of speech and swallowing.

5 Apr 2010

Detroit cancer center to conduct free oral, head and neck cancer screenings

On Friday, April 16, from 2 - 5 p.m., the Barbara Ann Karmanos Cancer Center in Detroit will be conducting free oral, head and neck cancer screenings in conjunction with National Oral Head and Neck Cancer Awareness Week (April 12 – 18.) Some of the symptoms of oral cancer go unnoticed. A simple 10-minute screening exam can determine if there are problems and can help diagnose this disease in its early stage.

3 Apr 2010

Identification and elimination of cancer stem cells

A new field of cancer research could explain why some cancers that appear to have been cured can rear their ugly head or spread to other organs.

3 Apr 2010

Cancer research at Georgia Tech: Report

Cancer treatment typically involves surgery, radiation therapy, chemotherapy, hormone therapy or biological therapy. An oncologist may use one therapy or a combination of methods, depending on the type and location of the cancer, whether the disease has spread, the patient's age and general health, and other factors.

3 Apr 2010

Harnessing body's own natural killer cells to battle cancer in children

Work underway at St. Jude Children's Research Hospital seeks to harnesses the body's own immune cells known as natural killer, or NK, cells to help children battle cancer. NK cells are the immune system's warriors. The cells circulate widely in the body, armed with proteins, called enzymes, capable of delivering a deadly one-two punch to viruses and cancer cells.

3 Apr 2010

CTRC commences enrollment in Phase 2 trial of REOLYSIN combination for SCC lung cancer

A virus that destroys cancer cells but leaves normal cells unharmed may offer hope to those affected by squamous cell carcinoma of the lungs (SCC lung cancer), according to investigators from the Cancer Therapy & Research Center (CTRC) at the University of Texas Health Science Center at San Antonio. The CTRC has started patient enrollment in a US Phase 2 clinical trial using intravenous administration of REOLYSIN® in combination with carboplatin and paclitaxel in patients with SCC lung cancer.

3 Apr 2010

SBRT effective in primary tumor control, study finds

Many of the world's leading radiation oncologists are employing the unique capabilities of SBRT to treat a variety of cancers that often have defied conventional radiation therapy techniques. A multitude of studies evaluating SBRT are ongoing and investigators are publishing articles that demonstrate the effectiveness of this technique. Two studies led by renowned radiation oncologists were conducted at centers that use Elekta SBRT technology, and their results were published recently.

From Elekta 2 Apr 2010

TCA may be an effective treatment option for patients who suffer from PVOD

Traditional Chinese acupuncture, where very thin needles are used to stimulate specific points in the body to elicit beneficial therapeutic responses, may be an effective treatment option for patients who suffer from persistent post- viral olfactory dysfunction, according to new research in the April 2010 issue of Otolaryngology - Head and Neck Surgery.

1 Apr 2010

Hemosphere completes $9.3M venture capital financing

Hemosphere, Inc., a private medical device company, has completed a late round of venture capital financing totaling $9.3 million. The company has developed the HeRO® Vascular Access Device, which provides access for hemodialysis - the process of filtering waste products from blood when kidneys are in renal failure - similar to a conventional graft.

1 Apr 2010

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

31 Mar 2010

INADA introduces new Sogno DreamWave Spa Massage Chair

World-leading distributor of massage chairs INADA, announced today its new Sogno DreamWave Spa Massage Chair in partnership with European Touch, the leading manufacturer of whirlpool pedicure spas.

31 Mar 2010

Signostics raises $5M in oversubscribed round of financing from new and existing investors

Signostics Inc., a U.S. and Australian-based medical device company developing revolutionary and affordable palm-sized ultrasound devices, has raised $5 million in an oversubscribed round of financing from new and existing investors. The company has raised a total of $19 million to date.

31 Mar 2010

Prevalence of head and neck cancer linked to human papillomavirus

Rates of oropharangeal cancer have increased by around 50 per cent in the last 20 years, according to a report in the British Medical Journal.

31 Mar 2010

EvoLife Laboratories introduces cancer care products in USA

EvoLife Laboratories, a world leader in the development of products for skin, oral, nail, hair, hygiene care specifically designed for cancer patients undergoing chemotherapy and radiotherapy, announced the launch of its products in USA.

31 Mar 2010